Tungsten Oxides: Why Early Testing Matters | Stevanato Group - Stevanato Group

Tungsten residues can impact biologics. Learn why early evaluation of drug–tungsten interactions is key to safe, stable injectable therapies.

Offizielle Website der Stevanato Group - Stevanato Group > News & Events - Stevanato Group > News - Stevanato Group > Tungsten Oxides: Why Early Testing Matters | Stevanato Group - Stevanato Group

page-wrapper

products

JUN 30 |

2022

Why it is Never Too Early to Consider Tungsten Interactions

products

JUN 30 |

2022

Why it is Never Too Early to Consider Tungsten Interactions

Andere News

products

The Superior Mechanical Resistance of Nexa® Vials for Improved Efficiency and Safety

JAN 08 |

2025

products

2R Vials and Deep Cold Storage - Determining Mechanical & CCI performances

NOV 15 |

2024

products

The Benefits of a Streamlined Approach to Drug Delivery Device Development

JUL 16 |

2024

products

The Superior Mechanical Resistance of Nexa® Vials for Improved Efficiency and Safety

JAN 08 |

2025

products

2R Vials and Deep Cold Storage - Determining Mechanical & CCI performances

NOV 15 |

2024

products

The Benefits of a Streamlined Approach to Drug Delivery Device Development

JUL 16 |

2024

⇽ Zurück zu News

Ihr Feedback ist uns wichtig
Es hilft uns, die Barrierefreiheit und Ihre Nutzererfahrung kontinuierlich zu verbessern

Kontaktieren Sie uns